Patent · US Active

Modular platform for targeted therapeutics

US11708421B2 · kind B2 · utility

0Cited by

8References

12Claims

0Family size

Assignee

Ramot at Tel-Aviv University Ltd. · IL

Inventors

Ranit Kedmi · Tel Aviv-Yafo, IL
Nuphar VEIGA · Yakum, IL
Itai Benhar · Rehovot, IL
Dan Peer · Kiryat Ono, IL

Key dates

Filing date	Jul 18, 2017
Grant date	Jul 25, 2023
Priority date	—
Expiry date	Jul 18, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/32
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A lipidated secondary antibody is disclosed. Particles comprising same are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.